About Serine/threonine-protein kinase H1
Serine/threonine-protein kinase H1 (PSKH1) is a protein
from Homo sapiens identified by UniProt accession
P11801, 424 residues long.
MolForge cross-references it against 0 known binders and
97 disease associations.
Target properties
| Protein name | Serine/threonine-protein kinase H1 |
| UniProt accession | P11801 |
| Gene | PSKH1 |
| Organism | Homo sapiens |
| Length | 424 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (97)
Diseases linked to this target (Open Targets).
- multiple sclerosis · score 0.37
- lysosomal storage disease · score 0.37
- neurodegenerative disease · score 0.37
- Alzheimer disease · score 0.37
- Parkinson disease · score 0.37
- high density lipoprotein cholesterol measurement · score 0.30
- apolipoprotein A 1 measurement · score 0.26
- hemoglobin measurement · score 0.23
- appendicular lean mass · score 0.22
- alcohol drinking · score 0.09
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P11801-F1 | alphafold | PREDICTED | 74.63 | — |
Amino-acid sequence (424 residues)
MGCGTSKVLP EPPKDVQLDL VKKVEPFSGT KSDVYKHFIT EVDSVGPVKA GFPAASQYAH PCPGPPTAGH TEPPSEPPRR ARVAKYRAKF DPRVTAKYDI KALIGRGSFS RVVRVEHRAT RQPYAIKMIE TKYREGREVC ESELRVLRRV RHANIIQLVE VFETQERVYM VMELATGGEL FDRIIAKGSF TERDATRVLQ MVLDGVRYLH ALGITHRDLK PENLLYYHPG TDSKIIITDF GLASARKKGD DCLMKTTCGT PEYIAPEVLV RKPYTNSVDM WALGVIAYIL LSGTMPFEDD NRTRLYRQIL RGKYSYSGEP WPSVSNLAKD FIDRLLTVDP GARMTALQAL RHPWVVSMAA SSSMKNLHRS ISQNLLKRAS SRCQSTKSAQ STRSSRSTRS NKSRRVRERE LRELNLRYQQ QYNG
Explore Serine/threonine-protein kinase H1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets